Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Sympatec is a leading provider of advanced particle characterization technologies, specializing in the development and manufacturing of instruments for particle size and shape analysis. Founded in 1984 as a spin-off from the Technical University of Clausthal, the company serves a wide range of industries, with a significant focus on the pharmaceutical and life sciences sectors. Their product portfolio includes laser diffraction, dynamic image analysis, and ultrasonic extinction systems designed for laboratory and process environments. These technologies are essential for ensuring the quality and efficacy of pharmaceutical formulations, such as dry powders, suspensions, and sprays. Sympatec is recognized for its innovation in modular instrumentation and its commitment to scientific precision in particle measurement. The company provides both laboratory-scale solutions and integrated process analytical technology for real-time monitoring in manufacturing lines.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Sympatec.